Bone Marrow TransplantationBone MarrowTissue DonorsTransplantation, HomologousHistocompatibility TestingBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseHistocompatibilityGraft SurvivalBone Marrow PurgingWhole-Body IrradiationTransplantation ChimeraBone and BonesTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaAnemia, AplasticHematopoietic Stem CellsSurvival AnalysisCombined Modality TherapyCyclophosphamideBone Marrow DiseasesLymphoma, Non-HodgkinCarmustineBusulfanRecurrenceTreatment OutcomeBone Marrow ExaminationGraft RejectionHematopoiesisRadiation ChimeraTransplantation, IsogeneicHLA AntigensTime FactorsLeukocyte TransfusionMice, Inbred C57BLRemission InductionBone Marrow NeoplasmsLeukemia, Myeloid, AcuteColony-Forming Units AssayMelphalanLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionActuarial AnalysisAntineoplastic Combined Chemotherapy ProtocolsBone RemodelingGraft Enhancement, ImmunologicAcute DiseaseImmunosuppressive AgentsLiver TransplantationTransplantation ToleranceT-LymphocytesEtoposideLeukemia, MyeloidHodgkin DiseaseKidney TransplantationStem Cell TransplantationSkin TransplantationCytarabineLymphocyte DepletionTransplantation ImmunologyDisease-Free SurvivalGraft vs Host ReactionHematologic NeoplasmsChimerismBone DensityRetrospective StudiesLiving DonorsCell DifferentiationHeart TransplantationMyelodysplastic SyndromesSurvival RateHematologic DiseasesTissue and Organ ProcurementHepatic Veno-Occlusive DiseaseMultiple MyelomaGranulocyte Colony-Stimulating FactorLymphomaBone ResorptionLeukocyte CountBlood DonorsFollow-Up StudiesFlow CytometryCells, CulturedMice, Inbred BALB CAntigens, CD34ChimeraBone TransplantationLymphocyte Culture Test, MixedGranulocytesDrug EvaluationVincristineThiotepaCell SeparationSalvage TherapyPodophyllotoxinBone NeoplasmsStromal Cells